Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluid

PK modeling successfully standardized ARV CSF concentrations to a given time point (i.e., C<sub>MAX</sub> or C<sub>Trough</sub>) to allow estimation of CSF penetration. This approach provides uniformity for the assessment of exposure, for the estimation of whether desired therapeutic drug goals are obtained in the CSF, and for further studies to investigate whether CSF exposure metrics calculated using this method are associated with measures of HIV persistence.

Authors

Institutions

Publication Details

Journal
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Published
2025-03-28
DOI
https://doi.org/10.1002/phar.70013
Primary Topic
Infectious Encephalopathies and Encephalitis
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluid

Anthony T. Podany, Ying Mu, Courtney Vail Fletcher, Joseph J. Eron et al.
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
Infectious Encephalopathies and Encephalitis
article

Pharmacokinetic approaches to standardize antiviral exposure in cerebrospinal fluid

Anthony T. Podany, Ying Mu, Courtney Vail Fletcher, Joseph J. Eron, Deborah K. McMahon, Jiajun Liu, Ronald J. Bosch, John W. Mellors, Rajesh T. Gandhi, Sean N. Avedissian, Serena Spudich, Caitlyn McCarthy
article en

Abstract

PK modeling successfully standardized ARV CSF concentrations to a given time point (i.e., C<sub>MAX</sub> or C<sub>Trough</sub>) to allow estimation of CSF penetration. This approach provides uniformity for the assessment of exposure, for the estimation of whether desired therapeutic drug goals are obtained in the CSF, and for further studies to investigate whether CSF exposure metrics calculated using this method are associated with measures of HIV persistence.

Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyVol. 45(5)
University of North Carolina at Chapel Hill (US), United States Food and Drug Administration (US), Harvard University (US), University of Pittsburgh (US), Yale University (US), Massachusetts General Hospital (US)
AIDS Clinical Trials Group, Harvard University Center for AIDS Research, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 91%
Infectious Encephalopathies and Encephalitis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.